Patent details

Basic Information

Publication number:

EP2379499

PCT Application Number:

PCT/US/2009/068352

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097934244

PCT Publication Number:

WO/2010/080455

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Hydrochloride salt of 1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl)-2-ethyl-benzyl)-azetidine-3-carboxylic acid

French Title of Invention:

SEL CHLORHYDRATE D'ACIDE 1-Ö4-Ö1-((E)-4-CYCLOHEXYL-3-TRIFLUOROMÉTHYL-BENZYLOXYIMINO)-ÉTHYLÜ-2-ÉTHYL-BENZYLÜ-AZÉTIDINE-3-CARBOXYLIQUE

German Title of Invention:

Hydrochlorid Salz der 1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl)-2-ethyl-benzyl)-azetidin-3-carbonsäure

SPC Number:

Dates

Filing date:

17/12/2009

Grant date:

09/04/2014

EP Publication Date:

09/04/2014

PCT Publication Date:

15/07/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/10/2011

EP B1 Publication Date:

09/04/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/12/2014

Expiration date:

17/12/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/12/2009

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

DE LA CRUZ Marilyn

Address:

United States (US)

2

Name:

KARPINSKI Piotr, H.

Address:

United States (US)

3

Name:

LIU Yugang

Address:

United States (US)

Priority

Priority Number:

203051 P

Priority Date:

18/12/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 205/04;

Filing date	Document type	Number of pages